Prevalence and types of extended spectrum β-lactamases among urinary Escherichia coli isolates in Moroccan community

Microbial Pathogenesis

Volumn 61-62, Issue , 2013, Pages 16-22

  Barguigua, Abouddihaj ^a,b   El Otmani, Fatima ^b   Talmi, Mustapha ^b   Zerouali, Khalid ^c   Timinouni, Mohammed ^a  

^a Institut Pasteur du Maroc   (Morocco)

^b FACULTÉ DES SCIENCES   (Morocco)

^c IBN ROCHD UNIVERSITY HOSPITAL   (Morocco)

Author keywords

lactamases; Escherichia coli; Moroccan community

Indexed keywords

AMIKACIN; CARBAPENEM; CEFOXITIN; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; KANAMYCIN; NALIDIXIC ACID; QUINOLONE; TETRACYCLINE; TOBRAMYCIN; TRIMETHOPRIM;

ADOLESCENT; ADULT; AGED; AMPC GENE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BLACTX M 1 GENE; BLACTX M 14 GENE; BLACTX M 15 GENE; BLACTX M 27GENE; BLACTX M 9 GENE; BLACTX M GENE; BLAOXA 1 GENE; BLASHV 12 GENE; BLASHV 125 GENE; BLASHV 27 GENE; BLASHV 28 GENE; BLASHV 36 GENE; BLATEM 1 GENE; BLATEM 3 GENE; BLATEM 70 GENE; CHILD; CLINICAL ARTICLE; ESBL GENE; ESCHERICHIA COLI; GENE IDENTIFICATION; GENETIC VARIABILITY; HUMAN; IMP 1 GENE; INTEGRON; NONHUMAN; OXA 48 GENE; PHENOTYPE; PHYLOGENY; PRESCHOOL CHILD; PRIORITY JOURNAL; URINARY TRACT INFECTION;

Β-LACTAMASES; ESCHERICHIA COLI; MOROCCAN COMMUNITY;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENETIC VARIATION; HUMANS; MICROBIAL SENSITIVITY TESTS; MOROCCO; PHYLOGENY; PLASMIDS; POLYMERASE CHAIN REACTION; PREVALENCE; URINARY TRACT INFECTIONS;

EID: 84878244698     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2013.04.010     Document Type: Article

References (31)

1. Celik A.D., Yulugkural Z., Kuloglu F., Eroglu C., Torol S., Vahaboglu H., et al. CTX-M type extended spectrum beta-lactamases in Escherichia coli isolates from community acquired upper urinary tract infections at a university in the European part of Turkey. Journal of Microbiology, Immunology, and Infection= Wei mian yu gan ran za zhi 2010, 43:163-167.
2. Ruppe E., Hem S., Lath S., Gautier V., Ariey F., Sarthou J.L., et al. CTX-M beta-lactamases in Escherichia coli from community-acquired urinary tract infections, Cambodia. Emerging Infectious Diseases 2009, 15:741-748.
3. Ruppe E. Épidémiologie des bêta-lactamases à spectre élargi: l'avènement des CTX-M. Antibiotiques (Paris) 2010, 12:3-16.
4. Barguigua A., El Otmani F., Talmi M., Bourjilat F., Haouzane F., Zerouali K., et al. Characterization of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates from the community in Morocco. Journal of Medical Microbiology 2011, 60:1344-1352.
5. Rodriguez-Bano J., Lopez-Cerero L., Navarro M.D., Diaz de Alba P., Pascual A. Faecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology. The Journal of Antimicrobial Chemotherapy 2008, 62:1142-1149.
6. Lahlou Amine I., Chegri M., L'Kassmi H. Épidémiologie et résistance aux antibiotiques des entérobactéries isolées d'infections urinaires à l'hÔpital militaire Moulay-Ismail de Meknès. Antibiotiques (Paris) 2009, 11:90-96.
7. Sekhsokh Y., Chadli M., El Hamzaoui S.A. Frequency and antibiotic susceptibility of bacteria identified in urine. Medecine et maladies infectieuses 2008, 38:324-327.
8. Benouda A., Touzani O., Khairallah M.T., Araj G.F., Matar G.M. First detection of oxacillinase-mediated resistance to carbapenems in Klebsiella pneumoniae from Morocco. Annals of Tropical Medicine and Parasitology 2010, 104:327-330.
9. Bouchakour M., Zerouali K., Gros Claude J.D., Amarouch H., El Mdaghri N., Courvalin P., et al. Plasmid-mediated quinolone resistance in expanded spectrum beta lactamase producing enterobacteriaceae in Morocco. Journal of Infection in Developing Countries 2010, 4:779-803.
10. Perez-Perez F.J., Hanson N.D. Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. Journal of Clinical Microbiology 2002, 40:2153-2162.
11. Queenan A.M., Bush K. Carbapenemases: the versatile beta-lactamases. Clinical Microbiology Reviews 2007, 20:440-458.
12. Tijet N., Alexander D.C., Richardson D., Lastovetska O., Low D.E., Patel S.N., et al. New Delhi metallo-beta-lactamase, Ontario, Canada. Emerging Infectious Diseases 2011, 17:306-307.
13. Clermont O., Bonacorsi S., Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Applied and Environmental Microbiology 2000, 66:4555-4558.
14. Escobar-Paramo P., Grenet K., Le Menac'h A., Rode L., Salgado E., Amorin C., et al. Large-scale population structure of human commensal Escherichia coli isolates. Applied and Environmental Microbiology 2004, 70:5698-5700.
15. Eckert C., Gautier V., Saladin-Allard M., Hidri N., Verdet C., Ould-Hocine Z., et al. Dissemination of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Paris, France. Antimicrobial Agents and Chemotherapy 2004, 48:1249-1255.
16. Mirelis B., Navarro F., Miro E., Mesa R.J., Coll P., Prats G. Community transmission of extended-spectrum beta-lactamase. Emerging Infectious Diseases 2003, 9:1024-1025.
17. Brinas L., Moreno M.A., Teshager T., Saenz Y., Porrero M.C., Dominguez L., et al. Monitoring and characterization of extended-spectrum beta-lactamases in Escherichia coli strains from healthy and sick animals in Spain in 2003. Antimicrobial Agents and Chemotherapy 2005, 49:1262-1264.
18. Moquet O., Bouchiat C., Kinana A., Seck A., Arouna O., Bercion R., et al. Class D OXA-48 carbapenemase in multidrug-resistant enterobacteria, Senegal. Emerging Infectious Diseases 2011, 17:143-144.
19. Johnson J.R., Kuskowski M.A., Owens K., Gajewski A., Winokur P.L. Phylogenetic origin and virulence genotype in relation to resistance to fluoroquinolones and/or extended-spectrum cephalosporins and cephamycins among Escherichia coli isolates from animals and humans. The Journal of Infectious Diseases 2003, 188:759-768.
20. Saeed M.A., Haque A., Ali A., Mohsin M., Bashir S., Tariq A., et al. Relationship of drug resistance to phylogenetic groups of E. coli isolates from wound infections. Journal of Infection in Developing Countries 2009, 3:667-670.
21. Rijavec M., Starcic Erjavec M., Ambrozic Avgustin J., Reissbrodt R., Fruth A., Krizan-Hergouth V., et al. High prevalence of multidrug resistance and random distribution of mobile genetic elements among uropathogenic Escherichia coli (UPEC) of the four major phylogenetic groups. Current Microbiology 2006, 53:158-162.
22. Skurnik D., Le Menac'h A., Zurakowski D., Mazel D., Courvalin P., Denamur E., et al. Integron-associated antibiotic resistance and phylogenetic grouping of Escherichia coli isolates from healthy subjects free of recent antibiotic exposure. Antimicrobial Agents and Chemotherapy 2005, 49:3062-3065.
23. Arpin C., Quentin C., Grobost F., Cambau E., Robert J., Dubois V., et al. Nationwide survey of extended-spectrum {beta}-lactamase-producing Enterobacteriaceae in the French community setting. The Journal of Antimicrobial Chemotherapy 2009, 63:1205-1214.
24. Poirel L., Ros A., Carrer A., Fortineau N., Carricajo A., Berthelot P., et al. Cross-border transmission of OXA-48-producing Enterobacter cloacae from Morocco to France. The Journal of Antimicrobial Chemotherapy 2011, 66:1181-1182.
25. Pitout J.D., Nordmann P., Laupland K.B., Poirel L. Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community. The Journal of Antimicrobial Chemotherapy 2005, 56:52-59.
26. Romero E.D., Padilla T.P., Hernandez A.H., Grande R.P., Vazquez M.F., Garcia I.G., et al. Prevalence of clinical isolates of Escherichia coli and Klebsiella spp. producing multiple extended-spectrum beta-lactamases. Diagnostic Microbiology and Infectious Disease 2007, 59:433-437.
27. Vignoli R., Varela G., Mota M.I., Cordeiro N.F., Power P., Ingold E., et al. Enteropathogenic Escherichia coli strains carrying genes encoding the PER-2 and TEM-116 extended-spectrum beta-lactamases isolated from children with diarrhea in Uruguay. Journal of Clinical Microbiology 2005, 43:2940-2943.
28. Pitout J.D., Gregson D.B., Church D.L., Laupland K.B. Population-based laboratory surveillance for AmpC beta-lactamase-producing Escherichia coli, Calgary. Emerging Infectious Diseases 2007, 13:443-448.
29. Hernandez-Alles S., Benedi V.J., Martinez-Martinez L., Pascual A., Aguilar A., Tomas J.M., et al. Development of resistance during antimicrobial therapy caused by insertion sequence interruption of porin genes. Antimicrobial Agents and Chemotherapy 1999, 43:937-939.
30. Namboodiri S.S., Opintan J.A., Lijek R.S., Newman M.J., Okeke I.N. Quinolone resistance in Escherichia coli from Accra, Ghana. BMC Microbiology 2011, 11:44.
31. Pitout J.D., Campbell L., Church D.L., Gregson D.B., Laupland K.B. Molecular characteristics of travel-related extended-spectrum-beta-lactamase-producing Escherichia coli isolates from the Calgary Health Region. Antimicrobial Agents and Chemotherapy 2009, 53:2539-2543.